Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Ionis Pharmaceuticals Price to Sales Ratio 2010-2025 | IONS

Historical PS ratio values for Ionis Pharmaceuticals (IONS) over the last 10 years. The current P/S ratio for Ionis Pharmaceuticals as of July 31, 2025 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Ionis Pharmaceuticals P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2025-08-01 43.03 7.52
2025-06-30 39.51 $5.72 6.90
2025-03-31 30.17 $4.79 6.30
2024-12-31 34.96 $4.78 7.31
2024-09-30 40.06 $5.53 7.24
2024-06-30 47.66 $5.64 8.46
2024-03-31 43.35 $5.41 8.01
2023-12-31 50.59 $5.50 9.19
2023-09-30 45.36 $4.31 10.53
2023-06-30 41.03 $4.43 9.27
2023-03-31 35.74 $4.05 8.82
2022-12-31 37.77 $4.14 9.12
2022-09-30 44.23 $6.19 7.14
2022-06-30 37.02 $6.01 6.16
2022-03-31 37.04 $5.96 6.22
2021-12-31 30.43 $5.75 5.29
2021-09-30 33.54 $4.71 7.13
2021-06-30 39.89 $4.91 8.12
2021-03-31 44.96 $5.06 8.88
2020-12-31 56.54 $5.23 10.82
2020-09-30 47.45 $6.37 7.45
2020-06-30 58.96 $6.39 9.22
2020-03-31 47.28 $6.52 7.25
2019-12-31 60.41 $7.66 7.88
2019-09-30 59.91 $5.87 10.20
2019-06-30 64.27 $5.76 11.16
2019-03-31 81.17 $5.51 14.74
2018-12-31 54.06 $4.56 11.86
2018-09-30 51.58 $4.46 11.57
2018-06-30 41.67 $4.35 9.58
2018-03-31 44.08 $4.34 10.16
2017-12-31 50.30 $4.11 12.23
2017-09-30 50.70 $4.33 11.72
2017-06-30 50.87 $4.27 11.90
2017-03-31 40.20 $3.69 10.91
2016-12-31 47.83 $3.07 15.60
2016-09-30 36.64 $1.95 18.75
2016-06-30 23.29 $1.46 15.90
2016-03-31 40.50 $2.09 19.39
2015-12-31 61.93 $2.31 26.82
2015-09-30 40.42 $2.60 15.55
2015-06-30 57.55 $2.56 22.45
2015-03-31 63.67 $2.11 30.22
2014-12-31 61.74 $1.82 33.91
2014-09-30 38.83 $1.48 26.20
2014-06-30 34.45 $1.31 26.24
2014-03-31 43.21 $1.18 36.67
2013-12-31 39.84 $1.36 29.22
2013-09-30 37.54 $1.18 31.85
2013-06-30 26.87 $1.09 24.67
2013-03-31 16.94 $1.21 13.99
2012-12-31 10.44 $1.02 10.26
2012-09-30 14.07 $1.14 12.29
2012-06-30 12.00 $1.24 9.70
2012-03-31 8.77 $1.01 8.65
2011-12-31 7.21 $0.99 7.25
2011-09-30 6.78 $0.94 7.24
2011-06-30 9.16 $1.02 9.01
2011-03-31 9.04 $1.00 9.00
2010-12-31 10.12 $1.09 9.25
2010-09-30 8.40 $1.16 7.26
2010-06-30 9.57 $1.14 8.39
2010-03-31 10.93 $1.22 8.96
2009-12-31 11.11 $1.24 8.95
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $6.851B $0.705B
Ionis Pharmaceuticals discovers/develops RNA-targeted therapeutics using its proprietary antisense oligonucleotide technology. Its antisense medicines have been developed/are being developed to treat neurological, cardiovascular and specialty rare diseases.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $79.248B 30.48
Zoetis (ZTS) United States $64.907B 24.22
Daiichi Sankyo, - (DSNKY) Japan $46.828B 24.00
Takeda Pharmaceutical (TAK) Japan $43.656B 8.91
BeOne Medicines - (ONC) Cayman Islands $33.004B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.084B 0.00
Summit Therapeutics (SMMT) United States $19.584B 0.00
Merck (MKKGY) Germany $16.168B 11.85
Shionogi (SGIOY) Japan $14.172B 14.20
Neurocrine Biosciences (NBIX) United States $12.718B 37.94
United Therapeutics (UTHR) United States $12.391B 10.72
Orion OYJ (ORINY) Finland $11.482B 27.67
IPSEN (IPSEY) France $10.802B 0.00
Stevanato Group S.p.A (STVN) Italy $7.483B 45.76
Grifols, S.A (GRFS) Spain $7.357B 0.00
Corcept Therapeutics (CORT) United States $7.123B 59.44
Madrigal Pharmaceuticals (MDGL) United States $6.717B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.853B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.358B 0.00
Hypermarcas (HYPMY) Brazil $2.987B 19.65
Crinetics Pharmaceuticals (CRNX) United States $2.677B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.602B 9.12
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.451B 13.25
NewAmsterdam Pharma (NAMS) Netherlands $2.449B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.294B 0.00
Ocular Therapeutix (OCUL) United States $1.845B 0.00
Endo (NDOI) United States $1.800B 0.00
ARS Pharmaceuticals (SPRY) United States $1.736B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.703B 0.00
Evotec AG (EVO) Germany $1.413B 0.00
Dyne Therapeutics (DYN) United States $1.401B 0.00
Guardian Pharmacy Services (GRDN) United States $1.323B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.249B 18.13
Harrow (HROW) United States $1.165B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.017B 0.00
Ardelyx (ARDX) United States $1.014B 0.00
Akebia Therapeutics (AKBA) United States $0.968B 0.00
Collegium Pharmaceutical (COLL) United States $0.959B 5.18
Enliven Therapeutics (ELVN) United States $0.923B 0.00
ProKidney (PROK) United States $0.811B 0.00
Xeris Biopharma Holdings (XERS) United States $0.796B 0.00
Cronos Group (CRON) Canada $0.764B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.716B 0.00
KalVista Pharmaceuticals (KALV) United States $0.681B 0.00
Zevra Therapeutics (ZVRA) United States $0.607B 0.00
Relay Therapeutics (RLAY) United States $0.603B 0.00
Xencor (XNCR) United States $0.592B 0.00
Organogenesis (ORGO) United States $0.586B 0.00
Tourmaline Bio (TRML) United States $0.568B 0.00
Theravance Biopharma (TBPH) United States $0.558B 0.00
USANA Health Sciences (USNA) United States $0.547B 11.01
Elite Pharmaceuticals (ELTP) United States $0.546B 0.00
Bioventus (BVS) United States $0.536B 13.58
Oruka Therapeutics (ORKA) United States $0.509B 0.00
Siga Technologies (SIGA) United States $0.472B 9.87
Savara (SVRA) United States $0.448B 0.00
Aquestive Therapeutics (AQST) United States $0.381B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.376B 10.17
AleAnna (ANNA) United States $0.339B 0.00
Nanobiotix S.A (NBTX) France $0.325B 0.00
Altimmune (ALT) United States $0.299B 0.00
Aldeyra Therapeutics (ALDX) United States $0.299B 0.00
Esperion Therapeutics (ESPR) United States $0.281B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.277B 0.00
Nektar Therapeutics (NKTR) United States $0.269B 0.00
Heron Therapeutics (HRTX) United States $0.264B 0.00
Nature's Sunshine Products (NATR) United States $0.259B 16.10
OmniAb (OABI) United States $0.233B 0.00
Galectin Therapeutics (GALT) United States $0.230B 0.00
Larimar Therapeutics (LRMR) United States $0.222B 0.00
4D Molecular Therapeutics (FDMT) United States $0.208B 0.00
MediWound (MDWD) Israel $0.201B 0.00
China SXT Pharmaceuticals (SXTC) China $0.181B 0.00
Lyell Immunopharma (LYEL) United States $0.175B 0.00
Journey Medical (DERM) United States $0.171B 0.00
Profound Medical (PROF) Canada $0.167B 0.00
Aclaris Therapeutics (ACRS) United States $0.166B 0.00
Liminatus Pharma (LIMN) United States $0.163B 0.00
Lexeo Therapeutics (LXEO) United States $0.157B 0.00
Korro Bio (KRRO) United States $0.140B 0.00
Avita Medical (RCEL) United States $0.140B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.124B 0.00
Cardiol Therapeutics (CRDL) Canada $0.123B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Inhibikase Therapeutics (IKT) United States $0.117B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Achieve Life Sciences (ACHV) Canada $0.091B 0.00
Fractyl Health (GUTS) United States $0.090B 0.00
Champions Oncology (CSBR) United States $0.087B 19.75
Metagenomi (MGX) United States $0.086B 0.00
Surrozen (SRZN) United States $0.086B 0.00
Avalo Therapeutics (AVTX) United States $0.085B 0.00
VAXART, INC (VXRT) United States $0.085B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
Nutriband (NTRB) United States $0.080B 0.00
Vivani Medical (VANI) United States $0.079B 0.00
PMV Pharmaceuticals (PMVP) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.069B 0.00
Inotiv (NOTV) United States $0.069B 0.00
Assertio Holdings (ASRT) United States $0.069B 0.00
Dominari Holdings (DOMH) United States $0.067B 0.00
Wellgistics Health (WGRX) United States $0.066B 0.00
Context Therapeutics (CNTX) United States $0.065B 0.00
Rafael Holdings (RFL) United States $0.059B 0.00
DURECT (DRRX) United States $0.058B 0.00
Telomir Pharmaceuticals (TELO) United States $0.056B 0.00
Unicycive Therapeutics (UNCY) United States $0.055B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 38.33
Century Therapeutics (IPSC) United States $0.047B 0.00
NRx Pharmaceuticals (NRXP) United States $0.047B 0.00
Jupiter Neurosciences (JUNS) United States $0.046B 0.00
Klotho Neurosciences (KLTO) United States $0.044B 0.00
Prelude Therapeutics (PRLD) United States $0.044B 0.00
Gain Therapeutics (GANX) United States $0.044B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Mural Oncology (MURA) Ireland $0.039B 0.00
Enlivex Therapeutics (ENLV) Israel $0.035B 0.00
PolyPid (PYPD) Israel $0.034B 0.00
Karyopharm Therapeutics (KPTI) United States $0.033B 0.00
Iterum Therapeutics (ITRM) Ireland $0.031B 0.00
Plus Therapeutics (PSTV) United States $0.029B 0.00
FibroGen (FGEN) United States $0.028B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.027B 0.00
Cosmos Health (COSM) United States $0.027B 0.00
Vivos Therapeutics (VVOS) United States $0.026B 0.00
Scienture Holdings (SCNX) United States $0.025B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Incannex Healthcare (IXHL) Australia $0.017B 0.00
BioLineRx (BLRX) Israel $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
Carisma Therapeutics (CARM) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
BioVie (BIVI) United States $0.011B 0.00
Ainos (AIMD) United States $0.011B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Lyra Therapeutics (LYRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
VYNE Therapeutics (VYNE) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
SHINECO (SISI) China $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 11.35
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.28
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00